370 related articles for article (PubMed ID: 30706544)
1. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death.
Yu Z; Zhou R; Zhao Y; Pan Y; Liang H; Zhang JS; Tai S; Jin L; Teng CB
Cell Prolif; 2019 Mar; 52(2):e12568. PubMed ID: 30706544
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
3. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
[TBL] [Abstract][Full Text] [Related]
6. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
Giannuzzo A; Pedersen SF; Novak I
Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
[TBL] [Abstract][Full Text] [Related]
7. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Effects of Glychionide-A Flavonoid in Human Pancreatic Carcinoma Cells Are Mediated by Activation of Apoptotic and Autophagic Pathways, Cell Cycle Arrest, and Disruption of Mitochondrial Membrane Potential.
Yu L; Chen M; Zhang R; Xu T
Med Sci Monit; 2019 Feb; 25():962-969. PubMed ID: 30712054
[TBL] [Abstract][Full Text] [Related]
9. New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
Kowalski S; Wyrzykowski D; Hac S; Rychlowski M; Radomski MW; Inkielewicz-Stepniak I
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634697
[TBL] [Abstract][Full Text] [Related]
10. Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (ΛΨm).
Du Y; Zhang J; Tao Z; Wang C; Yan S; Zhang X; Huang M
J BUON; 2019; 24(2):746-753. PubMed ID: 31128032
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of Copper Transporter-1 by Ammonium Tetrathiocarbolybdate in the Treatment of Pancreatic Cancer].
Zhao YN; Chen LH; Yang XL; Dong JY; Wu WB; Chen D; Geng RM; Ke NW; Liu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):643-649. PubMed ID: 32975078
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Hedgehog pathway induces autophagy in pancreatic ductal adenocarcinoma cells.
Xu Y; An Y; Wang X; Zha W; Li X
Oncol Rep; 2014 Feb; 31(2):707-12. PubMed ID: 24297612
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
[TBL] [Abstract][Full Text] [Related]
15. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
Elliott IA; Dann AM; Xu S; Kim SS; Abt ER; Kim W; Poddar S; Moore A; Zhou L; Williams JL; Capri JR; Ghukasyan R; Matsumura C; Tucker DA; Armstrong WR; Cabebe AE; Wu N; Li L; Le TM; Radu CG; Donahue TR
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6842-6847. PubMed ID: 30894490
[TBL] [Abstract][Full Text] [Related]
16. Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.
Xie J; Cheng CS; Zhu XY; Shen YH; Song LB; Chen H; Chen Z; Liu LM; Meng ZQ
Aging (Albany NY); 2019 May; 11(9):2681-2698. PubMed ID: 31076559
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer.
Aikawa T; Gunn J; Spong SM; Klaus SJ; Korc M
Mol Cancer Ther; 2006 May; 5(5):1108-16. PubMed ID: 16731742
[TBL] [Abstract][Full Text] [Related]
18. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
[TBL] [Abstract][Full Text] [Related]
19. A pectin-like polysaccharide from Polygala tenuifolia inhibits pancreatic cancer cell growth in vitro and in vivo by inducing apoptosis and suppressing autophagy.
Bian Y; Zeng H; Tao H; Huang L; Du Z; Wang J; Ding K
Int J Biol Macromol; 2020 Nov; 162():107-115. PubMed ID: 32531363
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma.
Yang W; Meng L; Chen K; Tian C; Peng B; Zhong L; Zhang C; Yang X; Zou J; Yang S; Li L
Cancer Sci; 2019 Apr; 110(4):1408-1419. PubMed ID: 30618127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
